Coronary atherosclerosis burden, but not transient troponin elevation, predicts long-term outcome in recreational

Stefan Möhlenkamp1, Kirsten Leineweber, Nils Lehmann

  • 1Clinic of Cardiology and Intensive Care Medicine, Bethanien Hospital Moers, Bethanienstrasse 21, 47441, Moers, Germany, stefan.moehlenkamp@bethanienmoers.de.

Insights

Transient increases in high-sensitive troponin I (hsTnI) during marathon running are linked to myocardial fibrosis. However, elevated hsTnI does not predict future coronary events or mortality in recreational runners.

Area of Science:

  • Cardiology
  • Sports Medicine
  • Biomarkers

Background:

  • Recreational marathon running can cause transient increases in high-sensitive serum troponin I (hsTnI).
  • The prognostic value of these hsTnI increases and their association with cardiovascular risk markers requires further investigation.

Purpose of the Study:

  • To determine the prognostic value of transient hsTnI increases during marathons.
  • To assess the association of hsTnI changes with traditional cardiovascular risk factors and imaging-based risk markers for coronary events and all-cause mortality in recreational marathon runners.

Main Methods:

  • Prospective study comparing 108 marathon runners with 864 age-matched and 216 age- and risk factor-matched controls.
  • hsTnI measured pre- and post-race in 74 runners.
  • Assessment of Framingham Risk Score (FRS), coronary artery calcium (CAC), and myocardial fibrosis via late gadolinium enhancement (LGE) using MRI.
  • Follow-up for coronary events and all-cause mortality over 6 ± 1 years.

Main Results:

  • 36.5% of runners exceeded the 99% hsTnI threshold (0.04 μg/L) post-race.
  • FRS, CAC, or LGE did not predict hsTnI levels or increases.
  • Runners with LGE showed higher post-race hsTnI and greater hsTnI increases compared to those without.
  • Coronary event rates were similar between runners and controls, but increased with higher CAC scores (p=0.002).
  • Prevalent LGE was associated with a higher prevalence of coronary events (57% vs 8%, p=0.003).
  • All-cause mortality was similar across all groups.

Conclusions:

  • Recreational marathon runners with myocardial fibrosis exhibit higher hsTnI levels during races.
  • Increasing coronary artery calcium and myocardial fibrosis, not hsTnI increases, are associated with higher coronary event rates.
  • Marathon running does not appear to increase all-cause mortality compared to matched controls.

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
6.8K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
500
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
961